Endocrinology

Latest News

ion Treatment is Potent Driver of Beta Cell Proliferation in Type 1 Diabetes Modelimage credit pancreatic islet cells: ©Paralogia/stock.adobe.com via AI
Novel Combination Treatment is Potent Driver of Beta Cell Proliferation in Type 1 Diabetes Model

July 12th 2024

In the mouse model of type 1 diabetes, a combined harmine/exendin-4 therapy resulted in an up to 7-fold increase in β cell numbers over 3 months, reported investigators.

Combined SGLT2i and GLP-1 RA Therapy Provides Complementary Cardiorenal Protection
Combined SGLT2i and GLP-1 RA Therapy Provides Complementary Cardiorenal Protection, According to Comprehensive Meta-Analysis

July 12th 2024

Remaining Free of Diabetes for at Least 4 Years Improves Long-Term Health in Persons with Impaired Glucose Tolerance
Remaining Free of Diabetes for at Least 4 Years Improves Long-Term Health in Persons with Impaired Glucose Tolerance

July 11th 2024

FDA Issues CRL to Novo Nordisk for Once-Weekly Insulin Icodec
FDA Issues CRL to Novo Nordisk for Once-Weekly Insulin Icodec

July 11th 2024

Workplace Sexual Harassment Linked to Higher Risk of Cardiometabolic Diseases: Daily Dose / image credit: ©New Africa/AdobeStock
Workplace Sexual Harassment Linked to Higher Risk of Cardiometabolic Diseases: Daily Dose

July 9th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.